These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22466536)
1. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning]. Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536 [TBL] [Abstract][Full Text] [Related]
2. [Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning]. Klin Med (Mosk); 2011; 89(6):56-9. PubMed ID: 22420197 [TBL] [Abstract][Full Text] [Related]
3. [Immune system disorders and their correction in critically ill patients with toxic and hypoxic encephalopathy]. Loladze A; Shilov V; Batotsyrenov B; Vasilyev S; Kuznetsov O Georgian Med News; 2012 Feb; (203):17-22. PubMed ID: 22466535 [TBL] [Abstract][Full Text] [Related]
4. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain]. Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Isakov VA; Kovalenko AL; Turkin VV; Makarov VI Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556 [TBL] [Abstract][Full Text] [Related]
6. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy]. Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products]. Shilov VV; Vasil'ev SA; Kuznetsov OA; Batotsyrenov BV; Loladze AT Med Tr Prom Ekol; 2012; (6):22-7. PubMed ID: 22997755 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection]. Mikhaĭlova EV; Danilova AN; Chudakova TK; Romanovskaia AV; Dubovitskaia NA; Belova AE Eksp Klin Farmakol; 2013; 76(8):43-6. PubMed ID: 24228490 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological correction of hypoxia in patients with severe carbon monoxide poisoning]. Shilov VV; Andrianov AIu; Vasil'ev SA; Batotsyrenova KhV; Loladze AT Georgian Med News; 2012 Apr; (205):31-8. PubMed ID: 22665729 [TBL] [Abstract][Full Text] [Related]
11. [Correcting posthypoxic damage of myocardium in newborns with cerebral ischemia]. Degtiareva EA; Romantsov MG; Zhdanova OI; Mikheeva AA; Avakian AA Eksp Klin Farmakol; 2010 Oct; 73(10):17-20. PubMed ID: 21254508 [TBL] [Abstract][Full Text] [Related]
12. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury]. Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of cognitive dysfunction in patients operated on thyroid gland]. Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909 [TBL] [Abstract][Full Text] [Related]
14. [Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass]. Tsygan IV Voen Med Zh; 2013 Nov; 334(11):30-5. PubMed ID: 24611306 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144 [No Abstract] [Full Text] [Related]
16. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency]. Beĭn BN; Dravert NE Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy]. Pochepen' ON Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910 [TBL] [Abstract][Full Text] [Related]
18. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316 [TBL] [Abstract][Full Text] [Related]
19. [The use of cytoflavin in combined neurometabolic therapy of acute cerebral insufficiency associated with acute poisoning with neurotropic poisons]. Aleksandrov MV; Vasil'ev SA; Kuznetsov OA; Andrianov AIu; Shikalova IA; Loladze AT; Batotsyrenov BV Klin Med (Mosk); 2010; 88(2):58-61. PubMed ID: 21105475 [TBL] [Abstract][Full Text] [Related]
20. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS]. Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]